To date, a number of studies have implicated the role of genetic polymorphism within ERCC2 gene in various cancers, such as gastric, pancreatic, glioma, bladder, and hepatocellular carcinoma [52,53,54,55,56,57]. This evidence concerns the gene ERCC2 and cancer.